Hepatitis C: Cure, but at What Cost?

Dr. Paul Sax considers how the high cost of sofosbuvir, simeprevir, and other potentially curative agents might affect their use in patients with HCV genotype 1 infection.

Source: Medscape Gastroenterology Podcast - April 29, 2014 Category: Gastroenterology Authors: Medscape Source Type: podcasts